Nitrogen-containing heterocyclic compound
US9662316B2 · kind B2 · utility
2Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2016 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Dec 22, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.The present invention relates to a compound represented by the formula (I) or a salt thereof.wherein each symbol is as described in the specification, or a salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.